236 related articles for article (PubMed ID: 22352903)
1. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
[TBL] [Abstract][Full Text] [Related]
2. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
3. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.
Arora S; Yang JM; Kinzy TG; Utsumi R; Okamoto T; Kitayama T; Ortiz PA; Hait WN
Cancer Res; 2003 Oct; 63(20):6894-9. PubMed ID: 14583488
[TBL] [Abstract][Full Text] [Related]
6. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
7. Reversible covalent inhibition of eEF-2K by carbonitriles.
Devkota AK; Edupuganti R; Yan C; Shi Y; Jose J; Wang Q; Kaoud TS; Cho EJ; Ren P; Dalby KN
Chembiochem; 2014 Nov; 15(16):2435-42. PubMed ID: 25224652
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors.
Edupuganti R; Wang Q; Tavares CD; Chitjian CA; Bachman JL; Ren P; Anslyn EV; Dalby KN
Bioorg Med Chem; 2014 Sep; 22(17):4910-6. PubMed ID: 25047940
[TBL] [Abstract][Full Text] [Related]
9. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screens for eEF-2 kinase.
Devkota AK; Warthaka M; Edupuganti R; Tavares CD; Johnson WH; Ozpolat B; Cho EJ; Dalby KN
J Biomol Screen; 2014 Mar; 19(3):445-52. PubMed ID: 24078616
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin.
Lee K; Alphonse S; Piserchio A; Tavares CD; Giles DH; Wellmann RM; Dalby KN; Ghose R
Structure; 2016 Sep; 24(9):1441-51. PubMed ID: 27499441
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.
Zhao YY; Tian Y; Liu L; Zhan JH; Hou X; Chen X; Zhou T; Huang Y; Zhang L
Drug Des Devel Ther; 2018; 12():2655-2663. PubMed ID: 30214154
[TBL] [Abstract][Full Text] [Related]
13. Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence.
Tavares CD; O'Brien JP; Abramczyk O; Devkota AK; Shores KS; Ferguson SB; Kaoud TS; Warthaka M; Marshall KD; Keller KM; Zhang Y; Brodbelt JS; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(11):2232-45. PubMed ID: 22329831
[TBL] [Abstract][Full Text] [Related]
14. eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells.
Tang XH; Wu XY; Xu L; Fang YX; Wang P; Zhu GX; Hong Z
PLoS One; 2015; 10(5):e0125389. PubMed ID: 25962137
[TBL] [Abstract][Full Text] [Related]
15. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
16. Regulation of elongation factor-2 kinase by pH.
Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
[TBL] [Abstract][Full Text] [Related]
17. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
[TBL] [Abstract][Full Text] [Related]
18. NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression.
Bender CL; Yang Q; Sun L; Liu SJ
Neuropharmacology; 2016 Feb; 101():531-7. PubMed ID: 25842244
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
Huber-Keener KJ; Evans BR; Ren X; Cheng Y; Zhang Y; Hait WN; Yang JM
Biochem Biophys Res Commun; 2012 Jul; 424(2):308-14. PubMed ID: 22749997
[TBL] [Abstract][Full Text] [Related]
20. Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.
Piserchio A; Will N; Giles DH; Hajredini F; Dalby KN; Ghose R
J Mol Biol; 2019 Jul; 431(15):2700-2717. PubMed ID: 31108082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
